Summer Sale

Up to 30% off — ends 7 Aug

ONLY00h00m00s

Get 30% Off

Up to 30% off — ends 7 Aug

ONLY00h00m00s

Eva Riveira Muñoz

AIDS Research Institute Irsicaixa

Spain

This profile is automatically generated from trusted academic sources.

Google Scholar

ORCID

How do I reach out?

Meet Kite AI

Contact this professor

ORCID

Google Scholar

Research Interests

Immunology

90%

Virology

100%

Sars-cov-2

60%

Cancer Biology

30%

Antiviral Therapy

30%

Inflammatory Biology

20%

Immune Response

20%

Ask ApplyKite AI

Start chatting

How can you help me contact this professor?

What are this professor's research interests?

How should I write an email to this professor?

Articles21

A human-ACE2 knock-in mouse model for SARS-CoV-2 infection recapitulates respiratory disorders but avoids neurological disease associated with the transgenic K18-hACE2 model.

Article Link

Year:

2025

Quality by Design-Guided Development of Hydrogel-Forming Microneedles for Transdermal Delivery of Enfuvirtide.

Article Link

Year:

2025

Targeting eEF1A reprograms translation and uncovers broad-spectrum antivirals against cap or m<sup>6</sup>A protein synthesis routes.

Article Link

Year:

2025

A monoclonal antibody targeting a large surface of the receptor binding motif shows pan-neutralizing SARS-CoV-2 activity

Article Link

Year:

2024

Immunisation efficacy of a stabilised SARS-CoV-2 spike glycoprotein in two geriatric animal models

Article Link

Year:

2024

SAMHD1 expression is a surrogate marker of immune infiltration and determines prognosis after neoadjuvant chemotherapy in early breast cancer

Article Link

Year:

2024

Immunization with V987H-stabilized Spike glycoprotein protects K18-hACE2 mice and golden Syrian hamsters upon SARS-CoV-2 infection

Article Link

Year:

2024

Nucleotide-Binding Oligomerization Domain 1 (NOD1) Agonists Prevent SARS-CoV-2 Infection in Human Lung Epithelial Cells through Harnessing the Innate Immune Response.

Article Link

Year:

2024

Sirtuin-2, NAD-Dependent Deacetylase, Is a New Potential Therapeutic Target for HIV-1 Infection and HIV-Related Neurological Dysfunction

Article Link

Year:

2023

SAMHD1 expression modulates innate immune activation and correlates with ovarian cancer prognosis

Article Link

Year:

2023

Comparison of Reverse Transcription (RT)-Quantitative PCR and RT-Droplet Digital PCR for Detection of Genomic and Subgenomic SARS-CoV-2 RNA

Article Link

Year:

2023

Novel Spike-stabilized trimers with improved production protect K18-hACE2 mice and golden Syrian hamsters from the highly pathogenic SARS-CoV-2 Beta variant

Article Link

Year:

2023

Author Correction to: SARS-CoV-2 interaction with Siglec-1 mediates trans-infection by dendritic cells.

Article Link

Year:

2022

IRF7 expression correlates with HIV latency reversal upon specific blockade of immune activation

Article Link

Year:

2022

Heterogeneous Infectivity and Pathogenesis of SARS-CoV-2 Variants Beta, Delta and Omicron in Transgenic K18-hACE2 and Wildtype Mice

Article Link

Year:

2022

A Cluster-Randomized Trial of Hydroxychloroquine for Prevention of Covid-19.

Article Link

Year:

2020

Hydroxychloroquine for Early Treatment of Adults with Mild Covid-19: A Randomized-Controlled Trial.

Article Link

Year:

2020

Erratum to: Pharmacological modulation of SAMHD1 activity by CDK4/6 inhibitors improves anticancer therapy (Cancers, (2020), 12)

Article Link

Year:

2020

New indolylarylsulfone non-nucleoside reverse transcriptase inhibitors show low nanomolar inhibition of single and double HIV-1 mutant strains

Article Link

Year:

2020

Pharmacological modulation of SAMHD1 activity by CDK4/6 inhibitors improves anticancer therapy

Article Link

Year:

2020

Targeting HIV-1 RNase H: N'-(2-Hydroxy-benzylidene)-3,4,5-Trihydroxybenzoylhydrazone as Selective Inhibitor Active against NNRTIs-Resistant Variants

Article Link

Year:

2020

Collaborators12

alfonso valencia

Research Professor

Instituciò Catalana de Recerca i Estudis Avancats

SPAIN

Ignacio Blanco

Universitat Autònoma de Barcelona (UAB)

SPAIN

Dominga Rogolino

University of Parma

ITALY

Mireia Margeli Vila

Universitat Autònoma de Barcelona (UAB)

SPAIN

Julià Blanco

Associate Professor

Universitat de Vic - Universitat Central de Catalunya

SPAIN

Javier Martinez-Picado

Associate professor

SPAIN

Julia G Prado

Principal Investigator , head of Virievac team

AIDS Research Institute Irsicaixa

SPAIN

Leire de Campos Mata

Karolinska Institutet

SWEDEN

Carlo Carolis

Head

SPAIN

Ignacio Martinez-Zalacain

Institut Mondor de recherche biomédicale

SPAIN

Christian Brander

ICREA Senior Research Professor

IrsiCaixa

SPAIN

Maria C. Puertas

AIDS Research Institute Irsicaixa

SPAIN

How do I reach out?

Meet Kite AI

Eva Riveira Muñoz

How do I reach out?

Contact this professor

Research Interests

Ask ApplyKite AI

Articles21

A human-ACE2 knock-in mouse model for SARS-CoV-2 infection recapitulates respiratory disorders but avoids neurological disease associated with the transgenic K18-hACE2 model.

Quality by Design-Guided Development of Hydrogel-Forming Microneedles for Transdermal Delivery of Enfuvirtide.

Targeting eEF1A reprograms translation and uncovers broad-spectrum antivirals against cap or m&lt;sup&gt;6&lt;/sup&gt;A protein synthesis routes.

A monoclonal antibody targeting a large surface of the receptor binding motif shows pan-neutralizing SARS-CoV-2 activity

Immunisation efficacy of a stabilised SARS-CoV-2 spike glycoprotein in two geriatric animal models

SAMHD1 expression is a surrogate marker of immune infiltration and determines prognosis after neoadjuvant chemotherapy in early breast cancer

Immunization with V987H-stabilized Spike glycoprotein protects K18-hACE2 mice and golden Syrian hamsters upon SARS-CoV-2 infection

Nucleotide-Binding Oligomerization Domain 1 (NOD1) Agonists Prevent SARS-CoV-2 Infection in Human Lung Epithelial Cells through Harnessing the Innate Immune Response.

Sirtuin-2, NAD-Dependent Deacetylase, Is a New Potential Therapeutic Target for HIV-1 Infection and HIV-Related Neurological Dysfunction

SAMHD1 expression modulates innate immune activation and correlates with ovarian cancer prognosis

Comparison of Reverse Transcription (RT)-Quantitative PCR and RT-Droplet Digital PCR for Detection of Genomic and Subgenomic SARS-CoV-2 RNA

Novel Spike-stabilized trimers with improved production protect K18-hACE2 mice and golden Syrian hamsters from the highly pathogenic SARS-CoV-2 Beta variant

Author Correction to: SARS-CoV-2 interaction with Siglec-1 mediates trans-infection by dendritic cells.

IRF7 expression correlates with HIV latency reversal upon specific blockade of immune activation

Heterogeneous Infectivity and Pathogenesis of SARS-CoV-2 Variants Beta, Delta and Omicron in Transgenic K18-hACE2 and Wildtype Mice

A Cluster-Randomized Trial of Hydroxychloroquine for Prevention of Covid-19.

Hydroxychloroquine for Early Treatment of Adults with Mild Covid-19: A Randomized-Controlled Trial.

Erratum to: Pharmacological modulation of SAMHD1 activity by CDK4/6 inhibitors improves anticancer therapy (Cancers, (2020), 12)

New indolylarylsulfone non-nucleoside reverse transcriptase inhibitors show low nanomolar inhibition of single and double HIV-1 mutant strains

Pharmacological modulation of SAMHD1 activity by CDK4/6 inhibitors improves anticancer therapy

Targeting HIV-1 RNase H: N'-(2-Hydroxy-benzylidene)-3,4,5-Trihydroxybenzoylhydrazone as Selective Inhibitor Active against NNRTIs-Resistant Variants

Collaborators12

alfonso valencia

Ignacio Blanco

Dominga Rogolino

Mireia Margeli Vila

Julià Blanco

Javier Martinez-Picado

Julia G Prado

Leire de Campos Mata

Carlo Carolis

Ignacio Martinez-Zalacain

Christian Brander

Maria C. Puertas

How do I reach out?

Targeting eEF1A reprograms translation and uncovers broad-spectrum antivirals against cap or m<sup>6</sup>A protein synthesis routes.